Search Results

0 results for 'Garwin Gerstein & Fisher LLP'

You can use to get even better search results
March 24, 2023 | The Legal Intelligencer

Kirkland & Ellis to Rep Teva in Pending Antitrust Class Action

This suit was surfaced by Law.com Radar. Read the complaint here.
2 minute read
February 08, 2023 | Law.com

Am Law 100 Offices Are Lacking in Efficiency: The Morning Minute

The news and analysis you need to start your day.
5 minute read
In re Seroquel XR Antitrust Litig.
Publication Date: 2022-07-19
Practice Area: Antitrust
Industry: Pharmaceuticals | Retail | State and Local Government
Court: U.S. District Court of Delaware
Judge: District Judge Connolly
Attorneys:
For plaintiff: Carmella P. Keener, Cooch and Taylor, P.A., Wilmington, DE; Bruce E. Gerstein, Joseph Opper, Kimberly M. Hennings, Daniel Litvin, Garwin Gerstein & Fisher LLP, New York, NY; Peter R. Kohn, Joseph T. Lukens, Faruqi & Faruqi, LLP, Philadelphia, PA; David F. Sorensen, Caitlin G. Coslett, Berger Montague PC, Philadelphia, PA; Stuart E. Des Roches, Amanda Hass, Chris Letter, Dan Chiorean, Thomas J. Maas, Odom & Des Roches, LLC, New Orleans, LA; Susan C. Segura, Erin R. Leger, David C. Raphael, Jr., Smith Segura Raphael & Leger, LLP, Alexandria, LA; Russell A. Chorush, Heim Payne & Cho Rush, LLP, Houston, TX; Michael J. Barry, Grant & Eisenhofer P.A., Wilmington, DE; Robert G. Eisler, Deborah A. Elman, Chad B. Holtzman, Grant & Eisenhofer P.A., New York, NY; Sharon K. Robertson, Donna M. Evans, Matthew W. Ruan, Cohen Milstein Sellers & Toll PLLC, New York, NY; Michael J. Barry, Grant & Eisenhofer P.A., Wilmington, DE; Jayne A. Goldstein, Shepherd, Finkelman, Miller & Shah, LLP, Media, PA; J. Clayton Athey, Jason Wayne Rigby, Prickett, Jones & Elliott, P.A., Wilmington, DE; Barry L. Refsin, Alexander J. Egervary, Caitlin V. McHugh, Hangley Aronchick Segal Pudlin & Schiller, Philadelphia, PA; Monica L. Kiley, Eric L. Bloom, Hangley Aronchick Segal Pudlin & Schiller, Harrisburg, PA; J. Clayton Athey, Jason Wayne Rigby, Prickett, Jones & Elliott, P.A., Wilmington, DE; Scott E. Perwin, Lauren C. Ravkind, Anna T. Neil, Kenny Nachwalter, P.A., Miami, FL; Heidi M. Silton, Jessica N. Servais, Lockridge Grindal Nauen P.L.L.P., Minneapolis, MN; Peter Safirstein, Safirstein Metcalf LLP, New York, NY; Archana Tamoshunas, Taus, Cebulash & Landau, LLP, New York, NY; Lee Albert, Brian D. Brooks, Glancy, Prongay, & Myrray, New York, NY; Robert J. Kriner, Jr., Tiffany Joanne Cramer, Chimicles Schwartz Kriner & Donaldson-Smith LLP, Wilmington, DE; Dianne M. Nast, Joseph N. Roda, Michael D. Ford, NastLaw, Philadelphia, PA; Michael L. Roberts, Stephanie E. Smith, Roberts Law Firm US, PC, Little Rock, AR for plaintiffs.
For defendant: Daniel M. Silver, Alexandrea M. Joyce, McCarter & English, LLP, Wilmington, DE; John E. Schmidtlein, Benjamin M. Greenblum, Colette T. Connor, Thomas S. Fletcher, Akhil K. Gola, Williams & Connolly, Washington, DC; Arthur G. Connolly, III, Alan Richard Silverstein, Connolly Gallagher LLP, Wilmington, DE; Christopher J. Marino, James E. Gallagher, Davis Malm & D'Agostine, P.C., Boston, MA; Jack B. Blumenfeld, Michael J. Flynn, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Stephen J. McIntyre, O'Melveny & Myers LLP, Los Angeles, CA; Brett J. Williamson, O'Melveny & Myers LLP, Newport Beach, CA; Ben Bradshaw, O'Melveny & Myers LLP, Washington, DC; John W. Shaw, Karen E. Keller, Nathan Roger Hoeschen, Shaw Keller LLP, Wilmington, DE; Thomas J. Lang, Christina E. Fahmy, Peter M. Boyle, Kilpatrick Townsend & Stockton LLP, Washington, DC for defendants.
Case number: D69888

Antitrust claims arising from alleged reverse payment agreements were timely under the statute of limitations where each alleged supracompetitive sale constituted a discrete act that started the limitations period for that sale.

In re Namenda Direct Purchasers Antitrust Litigation
Publication Date: 2020-06-25
Practice Area: Antitrust | Attorney Compensation
Industry: Pharmaceuticals
Court: U.S. District Court for the Southern District of New York, U.S. - SDNY
Judge: Chief Judge Colleen McMahon
Attorneys:
For plaintiff:
For defendant:
Case number: 15 Civ. 7488

Settlement Approved But Class Counsel Awarded Twice Inflated Lodestar as 'Success Fee'

In re: Lamictal Direct Purchaser Antitrust Litig.
Publication Date: 2020-05-04
Practice Area: Antitrust
Industry: Pharmaceuticals
Court: U.S. Court of Appeals for the Third Circuit
Judge: Justice Ambro
Attorneys:
For plaintiff: Daniel J. Bolan, Lindsay D. Breedlove, and Robin P. Sumner (Pepper Hamilton LLP); Joseph A. Fischetti and Gavin J. Rooney (Lowenstein Sandler LLP); Devora W. Allon, Jay P. Lefkowitz, and Dmitriy Tishyevich (Kirkland & Ellis LLP); Katherine M. Romano and Liza M. Walsh (Walsh Pizzi O’Reilly Falanga LLP)
For defendant: Elena K. Chan, Bruce E. Gerstein, Joseph Opper, and Noah Silverman (Garwin Gerstein & Fisher LLP); Caitlin G. Coslett and David F. Sorensen (Berger Montague); Matthew F. Gately and Peter S. Pearlman (Cohn Lifland Pearlman Herrmann & Knopf LLP); Peter R. Kohn and Joseph T. Lukens (Faruqi & Faruqi LLP); Stuart E. Des Roches, Chris Letter, and Dan Chiorean (Odom & Des Roches LLC); Susan C. Segura, David C. Raphael, Jr., and Erin R. Leger (Smith Segura Raphael & Leger LLP); Russell Chorush and Allan Bullwinkel (Heim Payne & Chorush LLP)
Case number: 19-1655

Class Certification Granted in Error When Experts Disputed Whether Proof of Damages Required Individualized Inquiry

April 23, 2020 | New Jersey Law Journal

Class Certification Reversed in Price-Fixing Lawsuit Over Lamictal Pay-for-Delay Deal

The panel found the trial judge granted certification without properly analyzing whether issues common to the class predominate over individual issues.
4 minute read
August 23, 2017 | New York Law Journal

Breaking With Magistrate, Judge Dismisses Expert Pharma Witness

Acknowledging the rarity of such a step, U.S. District Chief Judge Colleen McMahon of the Southern District of New York said she was compelled to break with a U.S. magistrate judge's recommendation to allow an expert to testify in a suit over Alzheimer's drugs.
11 minute read
August 23, 2017 | New Jersey Law Journal

In re: Lipitor Antitrust Litig.

Claims of Favorable Reverse Payment Settlement Agreements Were Sufficient to Constitute Allegation of Anticompetitive Activity
4 minute read
April 20, 2017 |

In re: Lipitor Antitrust Litig.

Action Did Not "Arise From" Patent Law Where Claim Could Succeed on Nonpatent Law Theory
25 minute read
September 13, 2016 |

Third Circuit Revokes Class Status in Provigil Antitrust Case

A federal appeals court stripped class status from direct purchasers of the narcolepsy drug Provigil, sending an antitrust case back to a lower court for a second look on class certification.
8 minute read

TRENDING STORIES

    Resources

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now

    • Countdown to Compliance: SEC Private Fund Reforms

      Brought to you by Ontra

      Download Now